We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
-21.24%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
-$183M
Cap. Flow
-$121M
Cap. Flow %
-58.33%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$3.09M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$92.3M
2
DNLI icon
Denali Therapeutics
DNLI
+$30.3M
3
MTCR
Metacrine, Inc. Common Stock
MTCR
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
$70.5M 34.02%
36,335,375
– –
DNLI icon
2
Denali Therapeutics
DNLI
$3.7B
$59.2M 28.57%
2,568,749
-1,100,000
-30% -$30.3M
ERAS icon
3
Erasca
ERAS
$6.66B
$33.3M 16.06%
11,055,554
– –
VERV
4
DELISTED
Verve Therapeutics
VERV
$29M 13.98%
2,008,809
– –
KRTX
5
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$5.45M 2.63%
30,000
-482,872
-94% -$92.3M
OMIC
6
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$4.6M 2.22%
126,631
– –
NTRA icon
7
Natera
NTRA
$38.1B
$3.58M 1.73%
+64,441
New +$3.09M
UBX
8
DELISTED
Unity Biotechnology
UBX
$1.64M 0.79%
1,004,817
– –
MTCR
9
DELISTED
Metacrine, Inc. Common Stock
MTCR
– –
-2,940,503
Closed -$1.32M

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q1 2023 Portfolio in Review

As of Q1 2023, Arch Venture Management held 9 positions worth $207M, down 47% from $390M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Arch Venture Management withdrew a net $121M in Q1 2023, closing 1 position and reducing 2 holdings. Its most notable exit was Metacrine, Inc. Common Stock, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Arch Venture Management opened a new position in Natera worth $3.58M.

  • Arch Venture Management's largest Q1 2023 buy was Natera: 64,441 shares worth $3.58M.
  • Arch Venture Management's biggest Q1 2023 reduction was Karuna Therapeutics, Inc. Common Stock, cutting an estimated $92.3M.
  • Arch Venture Management fully exited Metacrine, Inc. Common Stock in Q1 2023, selling an estimated $1.32M.
  • Arch Venture Management's ten largest holdings make up 100% of its $207M portfolio in Q1 2023.
  • Arch Venture Management opened 1 new position and closed 1 in Q1 2023.
  • Arch Venture Management's portfolio value fell 47% quarter-over-quarter to $207M.

Based on Arch Venture Management's 13F filing for Q1 2023, filed 15 May 2023.